Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07281989 · ClinicalTrials.gov registry record · NA

Sound Stops Stress Study: Evaluating the WAVwatch Effect

A NA study of Stress, sponsored by Efforia.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07281989: Recruiting NA study of Stress, sponsored by Efforia.

NCT07281989 is a NA study of Stress that is actively recruiting participants, run by Efforia. The registered enrollment target is 100 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07281989, a NA study of Stress, is actively recruiting participants, sponsored by Efforia.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Sound Off Stress Study seeks to discover if WAVwatch 2.0-a sleek, wearable sound frequency device-can support mental harmony.

Primary Outcome

The Perceived Stress Scale (Past Week Version) is a modified version of the classic stress assessment tool that evaluates stress levels based on recent experiences within the last week. This scale helps in understanding how various situations have recently affected an individual's feelings and perceived stress levels. By focusing on a shorter time frame, it provides a more immediate assessment of stress, which can be particularly useful for quickly evaluating the effectiveness of stress manageme

Conditions Studied

Interventions

  • DEVICE WAVWatch 2.0

Study Locations (1)

New York

  • Efforia - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-08-25
Est. Completion 2026-08-25
Phase NA
Efforia

19 total trials

What NCT07281989 shows while recruiting

NCT07281989 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 152 other Stress trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Stress appearing as the primary indexed condition, and to 1 intervention - of which WAVWatch 2.0 is the first listed.

NCT07281989 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT07281989 about?

NCT07281989 is a clinical study titled "Sound Stops Stress Study: Evaluating the WAVwatch Effect". Sound Off Stress Study seeks to discover if WAVwatch 2.0-a sleek, wearable sound frequency device-can support mental harmony.

What is the current status of trial NCT07281989?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-08-25. Estimated completion is 2026-08-25.

What conditions does trial NCT07281989 study?

This clinical trial studies the following conditions: Stress.

What interventions are being tested in trial NCT07281989?

The interventions under investigation include: WAVWatch 2.0 (DEVICE).

Who is sponsoring clinical trial NCT07281989?

This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07281989 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07281989's enrollment target sits among peer trials

100 65th of 152 higher than 86 of 152 other Stress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07281989, the US trial registry maintained by the National Library of Medicine. NCT07281989 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.